165 related articles for article (PubMed ID: 11903322)
1. Familial varieties of primary aldosteronism.
Stowasser M; Gunasekera TG; Gordon RD
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1087-90. PubMed ID: 11903322
[TBL] [Abstract][Full Text] [Related]
2. Familial hyperaldosteronism.
Stowasser M; Gordon RD
J Steroid Biochem Mol Biol; 2001 Sep; 78(3):215-29. PubMed ID: 11595502
[TBL] [Abstract][Full Text] [Related]
3. Primary aldosteronism: learning from the study of familial varieties.
Stowasser M; Gordon RD
J Hypertens; 2000 Sep; 18(9):1165-76. PubMed ID: 10994747
[TBL] [Abstract][Full Text] [Related]
4. New genetic insights in familial hyperaldosteronism.
Jackson RV; Lafferty A; Torpy DJ; Stratakis C
Ann N Y Acad Sci; 2002 Sep; 970():77-88. PubMed ID: 12381543
[TBL] [Abstract][Full Text] [Related]
5. Familial hyperaldosteronism.
Torpy DJ; Stratakis CA; Chrousos GP
Braz J Med Biol Res; 2000 Oct; 33(10):1149-55. PubMed ID: 11004715
[TBL] [Abstract][Full Text] [Related]
6. Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene.
Torpy DJ; Gordon RD; Lin JP; Huggard PR; Taymans SE; Stowasser M; Chrousos GP; Stratakis CA
J Clin Endocrinol Metab; 1998 Sep; 83(9):3214-8. PubMed ID: 9745430
[TBL] [Abstract][Full Text] [Related]
7. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22).
Lafferty AR; Torpy DJ; Stowasser M; Taymans SE; Lin JP; Huggard P; Gordon RD; Stratakis CA
J Med Genet; 2000 Nov; 37(11):831-5. PubMed ID: 11073536
[TBL] [Abstract][Full Text] [Related]
8. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 5: Genetic diagnosis of primary aldosteronism.
Zennaro MC; Jeunemaitre X
Ann Endocrinol (Paris); 2016 Jul; 77(3):214-9. PubMed ID: 27315758
[TBL] [Abstract][Full Text] [Related]
9. Primary aldosteronism.
Gordon RD
J Endocrinol Invest; 1995; 18(7):495-511. PubMed ID: 9221268
[TBL] [Abstract][Full Text] [Related]
10. Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity.
So A; Duffy DL; Gordon RD; Jeske YW; Lin-Su K; New MI; Stowasser M
J Hypertens; 2005 Aug; 23(8):1477-84. PubMed ID: 16003173
[TBL] [Abstract][Full Text] [Related]
11. [Familial hyperaldosteronism].
Spoto B; Furlò G; Gervasi A; Bresolin G; Zoccali C
G Ital Nefrol; 2004; 21(2):139-43. PubMed ID: 15351948
[TBL] [Abstract][Full Text] [Related]
12. Inherited Forms of Primary Hyperaldosteronism: New Genes, New Phenotypes and Proposition of A New Classification.
Perez-Rivas LG; Williams TA; Reincke M
Exp Clin Endocrinol Diabetes; 2019 Feb; 127(2-03):93-99. PubMed ID: 30199917
[TBL] [Abstract][Full Text] [Related]
13. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance.
Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
J Clin Endocrinol Metab; 2000 Jun; 85(6):2160-6. PubMed ID: 10852446
[TBL] [Abstract][Full Text] [Related]
14. Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families.
Sukor N; Mulatero P; Gordon RD; So A; Duffy D; Bertello C; Kelemen L; Jeske Y; Veglio F; Stowasser M
J Hypertens; 2008 Aug; 26(8):1577-82. PubMed ID: 18622235
[TBL] [Abstract][Full Text] [Related]
15. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
[TBL] [Abstract][Full Text] [Related]
16. Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism.
Stowasser M; Gordon RD; Tunny TJ; Klemm SA; Finn WL; Krek AL
Clin Exp Pharmacol Physiol; 1992 May; 19(5):319-22. PubMed ID: 1521363
[TBL] [Abstract][Full Text] [Related]
17. Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.
Adler G; Widecka K; Peczkowska M; Dobrucki T; Placha G; Drozd R; Parczewski M; Januszewicz A; Gaciong Z; Ciechanowicz A
J Appl Genet; 2005; 46(3):329-32. PubMed ID: 16110193
[TBL] [Abstract][Full Text] [Related]
18. Polyuric-polydipsic syndrome in a pediatric case of non-glucocorticoid remediable familial hyperaldosteronism.
Mussa A; Camilla R; Monticone S; Porta F; Tessaris D; Verna F; Mulatero P; Einaudi S
Endocr J; 2012; 59(6):497-502. PubMed ID: 22447138
[TBL] [Abstract][Full Text] [Related]
19. Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: no evidence for mutations in familial hyperaldosteronism type II in a large affected kindred.
Elphinstone MS; Gordon RD; So A; Jeske YW; Stratakis CA; Stowasser M
Clin Endocrinol (Oxf); 2004 Dec; 61(6):716-23. PubMed ID: 15579186
[TBL] [Abstract][Full Text] [Related]
20. A chimeric CYP11B1/CYP11B2 gene in glucocorticoid-insuppressible familial hyperaldosteronism.
Ise T; Shimoda A; Takakuwa H; Kato T; Izumiya Y; Shimizu K; Suzuki T; Sasano H; Yokoyama H; Kobayashi K
Clin Endocrinol (Oxf); 2001 Jul; 55(1):131-4. PubMed ID: 11453962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
